Merrimack Pharmaceuticals is an integrated, biopharmaceutical company committed to the innovation of life-enhancing medicines for the treatment of autoimmune disease and cancer. Merrimack is privately held and located in Cambridge, Massachusetts.

LATEST NEWS
December 7, 2009 - Press Release Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. October 1, 2009 - Merrimack Release Sanofi-aventis and Merrimack Pharmaceuticals enter into a Worldwide Collaboration and Licensing Agreement on MM-121, an anti-ErbB3 monoclonal antibody October 1, 2009 - sanofi-aventis Release Sanofi-aventis and U.S. Biotechnology company Merrimack enter into an Exclusive Global Collaboration and Licensing Agreement for a monoclonal antibody in Oncology   Merrimack Pharmaceuticals, Inc on Facebook